296 related articles for article (PubMed ID: 17892368)
1. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF
Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368
[TBL] [Abstract][Full Text] [Related]
2. Reverse phase protein microarrays for theranostics and patient-tailored therapy.
Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF
Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315
[TBL] [Abstract][Full Text] [Related]
3. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
4. Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
Wulfkuhle JD; Edmiston KH; Liotta LA; Petricoin EF
Nat Clin Pract Oncol; 2006 May; 3(5):256-68. PubMed ID: 16683004
[TBL] [Abstract][Full Text] [Related]
5. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
[TBL] [Abstract][Full Text] [Related]
6. High-throughput proteomics using antibody microarrays: an update.
Borrebaeck CA; Wingren C
Expert Rev Mol Diagn; 2007 Sep; 7(5):673-86. PubMed ID: 17892372
[TBL] [Abstract][Full Text] [Related]
7. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis.
Becker KF; Schott C; Hipp S; Metzger V; Porschewski P; Beck R; Nährig J; Becker I; Höfler H
J Pathol; 2007 Feb; 211(3):370-8. PubMed ID: 17133373
[TBL] [Abstract][Full Text] [Related]
8. Reverse phase protein microarrays for monitoring biological responses.
Espina V; Wulfkuhle JD; Calvert VS; Petricoin EF; Liotta LA
Methods Mol Biol; 2007; 383():321-36. PubMed ID: 18217695
[TBL] [Abstract][Full Text] [Related]
9. Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling.
Mattoon D; Michaud G; Merkel J; Schweitzer B
Expert Rev Proteomics; 2005 Dec; 2(6):879-89. PubMed ID: 16307517
[TBL] [Abstract][Full Text] [Related]
10. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
[TBL] [Abstract][Full Text] [Related]
11. Reverse-phase protein microarrays for tissue-based analysis.
Speer R; Wulfkuhle JD; Liotta LA; Petricoin EF
Curr Opin Mol Ther; 2005 Jun; 7(3):240-5. PubMed ID: 15977421
[TBL] [Abstract][Full Text] [Related]
12. Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
Voshol H; Ehrat M; Traenkle J; Bertrand E; van Oostrum J
FEBS J; 2009 Dec; 276(23):6871-9. PubMed ID: 19860827
[TBL] [Abstract][Full Text] [Related]
13. Protein arrays for biomarker discovery.
Reid JD; Parker CE; Borchers CH
Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
[TBL] [Abstract][Full Text] [Related]
14. Application of laser microdissection and reverse-phase protein microarrays to the molecular profiling of cancer signal pathway networks in the tissue microenvironment.
Espina V; Wulfkuhle J; Liotta LA
Clin Lab Med; 2009 Mar; 29(1):1-13. PubMed ID: 19389547
[TBL] [Abstract][Full Text] [Related]
15. Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer.
Pirnia F; Pawlak M; Thallinger GG; Gierke B; Templin MF; Kappeler A; Betticher DC; Gloor B; Borner MM
Proteomics; 2009 Jul; 9(13):3535-48. PubMed ID: 19609961
[TBL] [Abstract][Full Text] [Related]
16. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.
Gulmann C; Sheehan KM; Kay EW; Liotta LA; Petricoin EF
J Pathol; 2006 Apr; 208(5):595-606. PubMed ID: 16518808
[TBL] [Abstract][Full Text] [Related]
17. Functional protein arrays to facilitate drug discovery and development.
Michaud GA; Samuels ML; Schweitzer B
IDrugs; 2006 Apr; 9(4):266-72. PubMed ID: 16596480
[TBL] [Abstract][Full Text] [Related]
18. Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy.
Speer R; Wulfkuhle J; Espina V; Aurajo R; Edmiston KH; Liotta LA; Petricoin EF
Cancer Genomics Proteomics; 2007; 4(3):157-64. PubMed ID: 17878519
[TBL] [Abstract][Full Text] [Related]
19. Protein microarrays: a powerful tool to study cancer.
Sreekumar A; Chinnaiyan AM
Curr Opin Mol Ther; 2002 Dec; 4(6):587-93. PubMed ID: 12596361
[TBL] [Abstract][Full Text] [Related]
20. Protein-binding microarrays: probing disease markers at the interface of proteomics and genomics.
Kerschgens J; Egener-Kuhn T; Mermod N
Trends Mol Med; 2009 Aug; 15(8):352-8. PubMed ID: 19665433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
